Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label titration study of RO4389620 in type 2 diabetes mellitus
2006-000254-51Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of piragliatin in type 2 diabetes mellitus (T2DM), sponsored by Roche. Primary endpoint: FPG response without severe hypoglycemia. Started Apr 2006; status: completed.
02
Drugs
piragliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-000254-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000254-51.